Funded projects
The DCCC ctDNA Research Center support PhD projects focusing on documenting the positive effects of using ctDNA guidet cancer treatment.
Since 2020, the DCCC ctDNA center has co-financed the following projects.
Next deadline for applying for funding: the 26th of September 2022
OPTIMISE - OPTIMIzation of Treatment SElection and Follow up in Oligometastatic Colorectal Cancer - a ctDNA Guided phase II Randomized Approach
PhD student Louise Bach Callesen
Aarhus University Hospital
DETECT - Early detection of lung cancer by blood samples - A prospective national observational study
PhD student Sara Witting Christensen Wen
Vejle Sygehus
CURE - Clinical Utility of Circulating Tumor DNA in Gastro-Esophageal Cancer
PhD student Cecilie Riis Iden
Department of Oncology, Rigshospitalet
CIRCPAC– A National Randomized Trial Investigating the Clinical Benefit of circulating tumor DNA Guided Recurrence Surveillance After Resection for Pancreatic Cancer
Julia Sidenius Johansen, Professor, MD, DMSc
Herlev and Gentofte Hospital
Circulating Tumor DNA for early Detection of Recurrence and Risk-stratification in Melanoma
Lisbet Rosenkrantz Hölmich, Professor, MD, DMSc
Herlev and Gentofte Hospital
Early Detection of Treatment Failure by Circulating Tumor DNA in Advanced non-Small Cell Lung Cancer
Malene Støchkel Frank, Afdelingslæge, PhD student
Department of Clinical Oncology, Zealand University Hospital
Circulating Tumor-DNA for the Proper Allocation of Completion Resection in early Colorectal Cancer
Mads Klein, Associate professor
Herlev and Gentofte Hospital
Close Monitoring of Treatment Response of Patients with Metastatic Non-Small Cell Lung Cancer using Liquid Biopsy with focus on ctDNA methylation and ctRNA PD-L1 status
Christina Søs Audur Andersen, Molecular Biologist, PhD Student
Zealand University Hospital
NOAC 9 - A Phase II Randomised Nordic Anal Cancer Group Study on Circulating Tumor DNA guided Follow-Up
Overlæge Professor, PhD Dr.med., Karen-Lise Spindler
Eksperimentel Klinisk Onkologi, Aarhus University Hospital
ctDNA as Marker of Response and Recurrence in Patients with MMR-deficient Rectal Cancer Treated with Immunotherapy. A phase II Trial in Collaboration with Danish Colorectal Cancer Group (DCCG) and MOMA
Professor Per Pfeiffer
Department of Oncology, Odense University Hospital
CIRQUESARC - A National Prospective Observational Study of Circulating Tumor DNA and Quality of Life in Sarcomas
Clinical Oncologist, MD, Joanna Vitfell-Rasmussen, PhD student
Department of Oncology, Herlev University Hospital
ctDNA analysis of rectal cancer treated in the watchful waiting setting
PhD student Edina Dizdarevic
Department of Oncology, Vejle Sygehus
The Diverticulitis Study - Circulating tumor DNA guided vs. opportunistic colonoscopy screening for CRC detection after acute colonic diverticulitis
Professor Claus Andersen, M.Sc., Ph.D.
Department of Molecylar Medicine, Aarhus University Hospital
De novo cancer in liver transplant recipients (DETECT) – a ScandiaTransplant collaboration
Hans-Christian Pommergaard
Associate Professor, Department of Surgery and Transplantation, Rigshospitalet
ISCOLIM - Improving Survival of Colo-rectal Liver Metastase by RFA-mediated Immuno-stimulation
Preofessor Frank Viborg Mortensen, DMSc
Department of Surgery L, Aarhus University Hospital